← Back to all media
Is now the time to buy biotech shares?
Despite the recent dramatic correction in financial markets sparked by the COVID-19 fears and an oil price war, the U.S. equity market has notched up an impressive performance over the past 12 months. The NASDAQ 100 Index rose by 24.0% from 1 March 2019 to 29 February 2020. But the performance of the NASDAQ Biotech Index lagged, increasing by only 7.5% over the same period. That reflects a period of normalisation after a strong performance peaking in 2015.
Published on 11th March 2020